Willingness and Influencing Factors of Long-Term Drug Treatment in Endometriosis Patients

Jialan Chen
In: International Journal of Frontiers in Medicine · 2022 · vol. 4(9) · doi:10.25236/ijfm.2022.040901 · W4312845097
article OA: bronze CC0
📄 Open PDF View on OpenAlex View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This study investigated 200 endometriosis patients and found that diagnostic methods, pre-treatment pain, and disease cognition influenced treatment willingness, while drug use method affected treatment duration.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-06, 2026-06-08 ⓘ

This study investigated willingness to pursue long-term drug treatment and factors influencing treatment duration among 200 endometriosis patients admitted to Shaanxi Provincial People’s Hospital between June 2019 and December 2020, using health education plus questionnaires assessed before education, after education, and at a 6-month review. Using univariate and multivariate logistic regression, the authors found that diagnosis method, pre-treatment pain score, and endometriosis disease cognition were the main factors associated with treatment willingness, while age, education level, cyst diameter, and monthly treatment cost were not significant in the multivariate model. For treatment duration (persistent long-term drug treatment defined as ≥3 months versus 0–3 months), the drug use method was the key associated factor, with other evaluated variables not showing statistically significant effects. The paper’s limitation is that it is based on questionnaire-derived factors and a single-center sample with relatively short follow-up focused on willingness and persistence rather than long-term clinical outcomes. This paper is centrally about endometriosis — it analyzes patients’ willingness and influencing factors for long-term drug treatment in endometriosis.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Objective: To explore the long-term drug treatment willingness and influencing factors of endometriosis. Method: The information was collected from 200 endometriosis patients who were admitted to the gynecology clinic and ward of Shaanxi Provincial People’s Hospital from June 2019 to December 2020. Data was analyzed by univariate and multivariate logistic regression analysis. The influence of age, education level, diagnosis method, pre-treatment pain score, cyst diameter, EMs disease cognition and monthly treatment cost, pain relief satisfaction after treatment, drug toxicity tolerance and drug use method on the willingness and duration of long-term drug treatment was investigated. Results: The results of multivariate logistic regression analysis showed that diagnostic methods (OR = 0.304, 95% CI 0.127 - 0.728), pre-treatment pain score (OR = 1.415, 95% CI 1.237 - 1.620) and EMs disease cognition (OR = 1.058, 95% CI 1.030 - 1.087) were the main factors affecting the treatment willingness of EMs patients, and the drug use method was a key factor affecting the treatment duration (P<0.05). Conclusion: In the future, the adequate health education should be given to the EMs patients to promote their cognitive level of disease and recognition of diagnostic methods. At the same time, patients’ preferences for treatment measures should be combined to improve their long-term drug treatment willingness.

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (4)

References (5)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK